Export CSV
Subreddit: r/pennystocks clear
3 posts · sorted by score DESC
#SubredditTitleAuthorUpvotesRatioCmtsScoreSentimentKeywordDateLink
1r/pennystocks$SLS (Deepest Due Diligence for SLS-009, Machine Learning Models and Results, an...Confident-Web-71181650%13174.7stem cell therapy2026-03-17
commentercommentsentimentupvotes
u/outdoors_life22You sir have made the longest Reddit post that I have ever and probably will ever see53
u/CHE-B5Pfoh you accomplished a lot but men, that is a truly a though, technical read haha42
u/Yung_CeejayGreat post! This is still my largest holding!23
u/Practical_Ad_5875I’ve full ported this, could be my biggest regret or biggest achievement19
u/Muted-Extension-852117
u/Regular_Hawk8513I only have 120 shares, but I'm looking forward to what they become.16
u/Urkel____grueThanks for another great DD post. I am a big believer in $sls and hold five-digit worth of shares (and buying more when I can). I see your posts a lot and follow you on Stocktwits. I really do appreciate them very much, and have read all of your posts. The only two things that give me pause about your posts: you clam to have 800k shares. You don’t owe use anything at all, but can you share proof of holdings? That’s an insane investment and you must have more conviction about this stock than of any stock you’ve ever held as a DVI with that amount riding on a single stock. Secondly, if the math shows 99.99% success rate for just REGAL, what aren’t investment firms pouring hundreds of millions into SLS if it’s so surefire? I know there’s a lot of interest from investment firms but there’s not $1b+ pouring in. It can’t possibly be so surefire as you make it out to be Thanks again - I don’t want my slight skepticism to outweigh the due diligence you’re sharing. It’s just, the amount of shilling from an account that only shills about a single stock raises flags for me. Cheers14
u/Playful_Criticism425What the helly.8
u/Used-Motor8283I'm balls deep in SLS8
u/Confident-Web-7118I am an SLS holder. I personally believe that SLS will have a premium with it essentially becoming an AML monopoly in the best case, with some platform optionality. My best guess would be somewhere in the 3-8 billion range. Perhaps higher if results are exceptional. But any ideas that SLS buyout will be in the 20 Billion+ range is folly. That would essentially make SLS worth around the same Moderna and BionTech, which have a platform proven for multiple indications. Sellas at best has two indications without further research/development. For a company to conduct many, perhaps dozens of clinical trials to truly create a platform, it would take billions of dollars in RnD. That is why they will offer a discounted price to future potential.6
u/Federal-Snow1914Really appreciate this and your other posts. I’m heavy into $SLS as well. A few questions to hep me understand your confidence for you since I can’t fully grasp all of your analysis: Have you ever been this confident in a stock and missed the mark? What percentage of your own portfolio is in $SLS? Are you betting the farm? Thanks again for sharing all of your work!5
u/MaxTrade84As someone who went through treatment for Leukemia (not AML) I appreciate the depth of research and am now a shareholder. Thanks!5
u/Tantpispourtoi5
u/ambassador3215
u/National_Major_9356Holy... this is impressive. I really apperciate your work. I can't even argue with what's been written, so I have to go in with a small position; I'll be watching this very closely.5
u/SavingsMortgage1972Frankly, I didn't read any of this so I have no idea if you overfit your models to hell but you convinced me to put 10 racks into this lets print money.5
u/Accurate_Pay_2242Holding for the BO4
u/altiifGod, I hope you’re right. I have 4400 shares at around $2 based on a random post I saw on Reddit. Definitely have made money but am holding on for the long haul. Amazing analysis and work that you put in - even if it doesn’t end up being correct. I admire the dedication and level of nerdiness.4
u/BehemothslayerTLDR, what’s the ticker that I’m buying??4
u/sterculese89I caaaaint reaaad4
u/PhebreGreat work, thank you3
u/BariBlueYou are a very intelligent person and I do my best to read all of your DDs to get even more of an understanding of what we own. With that being said I’m curious in what you do for a living if you don’t mind sharing or can give vague details. These models and over all DD is some of the best I’ve seen since being in the market the last 7-8 years. I know there is no such thing as a sure thing, but you’ve convinced me this is. If the 80th event occurs earlier than expected let’s say Q2 for example. Will the stock run on the great news or will there be no movement until a buyout is officially in discussion? Thanks for all the hard work you do and hope you can answer my questions if you have time.3
u/Desperate-Ring12😎😎3
u/Antonio-BamaoI am in. And I think you can publish one SCI paper using these meta-review data😊😁3
u/Admirable_Ad5134this is insane. props to you man. great work <33
u/Low-Childhood-748Its an incredible analyses, and u are to be congraulated for all the work you put into it. What was not factored in was the testimony of the leading enroller-of course that is not math, nevertheless its important. Dr. Tsirgiotis is convinced that the extended survival being seen is due to the GPS effect. He already explained that his patients were experiencing a better QQL, which makes sense since GPS lacks the cytopenias cuased by hypomethylating agents. Interestingly on the last KOL call, he pushed to study GPS in post transplant maintenance. An academic Hematologist would not push for this unless he was convinced of the effect. Moreover, 2 weeks ago we saw a linked in exchange between a Myeloma KOL and the CEO again where there was interest in evaluating GPS in the MM maintenance setting. My expertise was in KOL management and behavior, and I have a robust amount of shares, but what are the limitatons of the machine model? Could one argue that at the end of all this analyses, the model only has predicted the direction of the survival benefit???3
u/Ateyo94If regal fails we probably won’t get much out of sls900 right? When do you predict the 80th event will happen2
u/TheGoodSaladYou've mentioned a lot of positives, is there anything to be worried about/ anything that could throw this out? No matter how unlikely2
u/Ok-Rock7488I have thousands of shares. I want to buy more but I’m also building into another biotech that I believe will return good results. It’s about choice. Which do I top up. Probably going to let me sls position ride. Good luck everyone. Especially the patients.2
u/Interesting-Play-489Anyone who hasn’t seen the RD video from last fall and witnessed the giddy joy of Dr. Kahn as he talks about 009 should really do so.2
u/kroefRemindMe! 18 months2
u/[deleted]Well researched and thought out. Well done!2
u/Deep_Development3814Do you envision 3.50 could be an entry point?1
u/Low_Sheepherder7990My one and only critique of SLS… your buying a lotto ticket and waiting for a buyout. It will guarantee make you money… I have no doubt there. But in 5 weeks? 5 months? Two years? That unknown timetable and opportunity cost keeps me from going heavy on this one.1
u/Tom9274Firstly, thankyou for your efforts here. The time you've put into this is truly appreciated. Secondly do you have a Github repo to share? I feel I'd probably learn a lot going through your code.1
u/moreheart3Thank you so much!!! Are there any other pennystocks where you see a similar potential and evidence behind it? I‘d appreciate your insights🙏1
u/kroefRemindMe! 1 day1
u/shinigamislikapplesOh fudge that's deep1
u/DawctorMeNice DD again. You mention Keytruda as a potential trajectory, but not as a potential GPS partner. Merck and Sellas did the PT resistant ovarian trial, where merck supplied Keytruda for the trial. Do you think there's potential on Merck also being interested in (atleast) GPS? Biologically the PD1 + GPS combo seems like a good pair. Sorry if you've adressed this in your other posts or comments. I might have missed it, perhaps not.1
u/ExpertMycologist8149Alles gut aber schlussendlich ist es eine hochriskante Aktie. Das muss man eingestehen.1
u/Pretend-Comfort-2569Hey OP, I’m not biotech native in anyway and ran all your DD through Claude and this was the output. https://claude.ai/public/artifacts/91d890dc-e4cb-4d9a-8682-289b676cbbe3 Would appreciate your response to the following points that highlights skeptics. Thank you :)1
u/rockhao781Can you teach me how to build your ML models?1
u/PennyPumperDoes this submission fit our subreddit? If it does please upvote this comment. If it does not fit the subreddit please downvote this comment. I am a bot, and this comment was made automatically. Please contact us via modmail if you have any questions or concerns.
u/iplay4HimWell done. I have an off topic question. My biggest concern, legitimately, is AI. I truly believe AI is about to change everything in the next 12-36 months as it quickly passes human intelligence. If that does occur, not only will it have been a better investment than almost anything, but it could render most modern medicines obsolete as it creates more effective medicines overnight. Any thoughts? Just curious.
u/Better-Salad-1442The amount of these types of posts on this specific name is among the most bearish signals I’ve seen-3
u/Delancey1From 200k to penny, no thanks-7
#SubredditTitleAuthorUpvotesRatioCmtsScoreSentimentKeywordDateLink
2r/pennystocksModel to pre-screen potential multibaggersHefty_Vermicelli_802200%2661.1regenerative medicine2026-03-14
commentercommentsentimentupvotes
u/passionlessDroneDon’t see SLS. Fake news?3
u/narayan77I expect RZLV will re-rate according to the model, if they can prove their projections by audited earnings.2
u/UnbrokenChillWould love to see PSSOF, HYLN, HYSR, and my current multi bagger HGRAF. Particularly interested in HGRAF and PSSOF. Appreciate your work. I'd love to see more of the model and how it works.2
u/Rochetechnology1Sound interesting2
u/HEK293INVAXwill be interesting to see if it catches the up and coming 10x baggers in oil production like EONR BRN YGRAF -unless you think $120 oil isn't going to be sticky.1
u/JCJENSON_Pr_Dept_6Would you mind providing links to the studies? I can't seem to find anything especially for the credit suisse study?1
u/trshmstrRequest for HGRAF, DRTS & CTM1
u/Digital_NarThe framework itself is interesting, but the reality is that most of those categories break down when you move into penny stock territory. The model was clearly inspired by studies on compounders and 100 baggers, which usually apply to quality growth companies, not microcaps in my humble opinion. That said have you experimented with compressing the model for small caps? For example focusing the score on a few key variables like capital structure, dilution risk, revenue acceleration, and catalyst density rather than the full framework. Could be interesting to see if the model behaves differently when applied to sub-$300M companies.1
u/EmbarrassedPart1256It's wild how $CAPS doesn't come up on anyone's scanners when it continually comes up on various ones I do, the same ones that I used to find $CTM @ $.18...🤔1
u/Responsible_Newt9644Neat. It’s a good idea. I’ve been looking at krakens success as a recent penny stock graduate and seeing where I can draw parallels in the penny stock I own. What if your model only uses recent penny stock graduates?1
u/StealthlessCTM two straight weeks of decline btw1
u/ScarShot587CTM is undervalued right now1
u/Horror-Pack-8319Great post - thanks for this1
u/PennyPumperDoes this submission fit our subreddit? If it does please upvote this comment. If it does not fit the subreddit please downvote this comment. I am a bot, and this comment was made automatically. Please contact us via modmail if you have any questions or concerns.
#SubredditTitleAuthorUpvotesRatioCmtsScoreSentimentKeywordDateLink
3r/pennystocksUpcoming penny stock catalysts for Q1/Q2 2026 in Biotech and PharmaAvish_Golakiya1020%4855.2regenerative medicine2026-03-10
commentercommentsentimentupvotes
u/J0hnnyBlazer22
u/BasilWithWaterRCKT let's go!9
u/Avish_GolakiyaNot promoting this at all, just sharing my take since I’ve got an avg around $3.2 RCKT (KRESLADI) PDUFA Mar 28, now stock is around $5.24. Probably the cleanest high PoA setup on the calendar right now. Gene therapy for LAD-I, and it’s already doing that quiet, steady grind up. No crazy hype yet, just slowly building. 76% PoA is pretty strong, and these names often get front-run when the risk/reward looks this clean.9
u/Likes_The_ScotchWaiting for ELTP the swing back upward. It’s been floating around $.40 for too long now. Anywhere but up6
u/North_Welcome_3249Glad to see ATAI on there.5
u/thepoisonpoodleHow is PoA derived?4
u/Stitch426Avish, is there any update on MDAI? They submitted for FDA approval June 20253
u/RandyMarshFundYou are missing IronWood Pharmaceuticals2
u/Business_Mixture_139Srxh??? Reverse merger coming soon1
u/Competitive_Nail_159bhvn stock1
u/Get_rch_or_try_dyinThanks ! I bought a pile of RCKT the last few weeks. I’ve also got a large pile of IMRX . I think it has some huge potential through 2026 !1
u/MainDark3321No love for LPCN and their phase 3 PPD data readout coming in early April. They clarified that timeline in yesterday's press release for their annual report.1
u/Shot_Truth_5701Geovax GOVX- Bought in after last capital raise recently. Worth a look. <image>1
u/GreenSouth3SRXH1
u/OldTeaching8407Put this in a ETf basket would be dope1
u/StretchMinuteBREAKING: Check out SCNX-- on fire today. Just the beginning!1
u/iamWfdupWhat's the status on ALMS, and PVLA?1
u/Ordinary-Evening552Aldx high chances of approval today.1
u/darkknight-6Thanks for sharing. What are your thoughts on ALDX?1
u/PennyPumperDoes this submission fit our subreddit? If it does please upvote this comment. If it does not fit the subreddit please downvote this comment. I am a bot, and this comment was made automatically. Please contact us via modmail if you have any questions or concerns.
u/turnleftorrightblockTy.
u/Affectionate_Strain6INTS-1